Company: Tchaikapharma High Quality Medicines AD-Sofia (THQM)
The Commercial Register refused through a notice of rejection to register the capital increase of Tchaikapharma High Quality Medicines AD (THQM) as per the decision adopted by the GMS held on 20 June 2023. In this regard, BSE reinstates the parameters of the financial instrument in the historical data to the state before 03 July 2023, applying a correction factor of 1.05089.
Therefore, as of 01 April 2024, the market capitalisation of the company will be calculated on the basis of 84,500,000 shares.
Attachments
- Original Link
- Permalink
Disclaimer
Tchaikapharma High Quality Medicines AD published this content on 28 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 March 2024 16:45:45 UTC.